Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/669754


Republic of Korea In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012


Description: Republic of Korea In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Republic of Korea IIn vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Republic of Korea

Scope

- The report provides in vitro diagnostics information broken down into detailed categories and segments in Republic of Korea.
- Total revenues, end users
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the in vitro diagnostics devices market in Republic of Korea.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Contents: 1 Table Of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Introduction 11
2.1 What Is This Report About? 11
3 Definitions of Markets Covered in the Report 12
3.1 In Vitro Diagnostics Devices 12
3.2 Clinical Chemistry Test Reagents 12
3.3 Immunochemistry Test Reagents 12
3.4 Blood Test Reagents 14
3.5 Microbiology Test Reagents 16
3.6 Infectious Immunology Test Reagents 17
3.7 Genetic Test Reagents 18
3.8 Self Testing 18
3.9 Instruments 18
4 Healthcare Sector Review 19
4.1 Healthcare Expenditure 19
4.2 Healthcare Infrastructure 21
4.3 Healthcare Policy 25
5 Regulation System 26
5.1 Medical Equipment Approval Process 26
5.2 Post-market Surveillance 29
6 Pricing and Reimbursement 30
7 Distribution Structure 33
7.1 Distribution Structure 33
8 In Vitro Diagnostics In Republic of Korea 34
8.1 In Vitro Diagnostics Cross Country Comparison (2000-2012) 34
8.2 In Vitro Diagnostics, Republic of Korea, Overall Revenues ($ mn), 2000-2012 35
8.3 In Vitro Diagnostics, Republic of Korea Company Share (2006-2007) 41
9 Blood Test Reagents In Republic of Korea 42
9.1 Blood Test Reagents Overall Revenue (2000-2012) 42
9.2 Blood Test Reagents Distribution Share (2006-2007) 50
9.3 Blood Test Reagents, Republic of Korea, Company Share (2006-2007) 51
10 Clinical Chemistry Test Reagents In Republic of Korea 52
10.1 Clinical Chemistry Test Reagents Overall Revenue (2000-2012) 52
10.2 Clinical Chemistry Test Reagents Distribution Share (2006-2007) 54
10.3 Clinical Chemistry Test Reagents, Republic of Korea, Company Share (2006-2007) 55
11 Genetic Test Reagents In Republic of Korea 56
11.1 Genetic Test Reagents Overall Revenue (2000-2012) 56
11.2 Genetic Test Reagents Distribution Share (2006-2007) 58
11.3 Genetic Test Reagents, Republic of Korea, Company Share (2006-2007) 59
12 Immunochemistry Test Reagents In Republic of Korea 60
12.1 Immunochemistry Test Reagents Overall Revenue (2000-2012) 60
12.2 Immunochemistry Test Reagents Distribution Share (2006-2007) 72
12.3 Immunochemistry Test Reagents, Republic of Korea, Company Share (2006-2007) 73
13 Infectious Immunology Test Reagents In Republic of Korea 74
13.1 Infectious Immunology Test Reagents Overall Revenue (2000-2012) 74
13.2 Infectious Immunology Test Reagents Distribution Share (2006-2007) 80
13.3 Infectious Immunology Test Reagents, Republic of Korea, Company Share (2006-2007) 81
14 Instruments In Republic of Korea 82
14.1 Instruments Overall Revenue (2000-2012) 82
14.2 Instruments Distribution Share (2006-2007) 84
15 Microbiology Test Reagents In Republic of Korea 85
15.1 Microbiology Test Reagents Overall Revenue (2000-2012) 85
15.2 Microbiology Test Reagents Distribution Share (2006-2007) 88
15.3 Microbiology Test Reagents, Republic of Korea, Company Share (2006-2007) 89
16 Self Testing In Republic of Korea 90
16.1 Self Testing Overall Revenue (2000-2012) 90
16.2 Self Testing Distribution Share (2006-2007) 92
16.3 Self Testing, Republic of Korea, Company Share (2006-2007) 93
17 F. Hoffmann-La Roche Ltd. Company Profile 94
17.1 Company Overview 94
17.2 Value Chain Analysis 94
18 Abbott Laboratories Company Profile 97
18.1 Company Overview 97
18.2 Value Chain Analysis 97
19 Beckman Coulter, Inc. Company Profile 101
19.1 Company Overview 101
19.2 Value Chain Analysis 101
19.3 Beckman Coulter, Inc. Pipeline Products 103
20 Dade Behring Holdings, Inc. Company Profile 106
20.1 Company Overview 106
21 Ortho-Clinical Diagnostics Inc. Company Profile 107
21.1 Company Overview 107
22 Becton, Dickinson and Company Company Profile 108
22.1 Company Overview 108
22.2 Value Chain Analysis 108
23 Bioneer Corporation Company Profile 110
23.1 Company Overview 110
24 Biospace Co.,Ltd. Company Profile 111
24.1 Company Overview 111
25 Boditech Med Inc. Company Profile 112
25.1 Company Overview 112
26 Financial Deals Landscape 113
26.1 Detailed Deal Summary 113
27 Appendix 114
27.1 Global Markets Direct Research Methodology 114
27.2 Coverage 115
27.3 Secondary Research 115
27.4 Primary Research 116
27.5 Models 116
27.6 Forecasts 117
27.7 Expert Panels 117
27.8 Currency Conversion 118
27.9 Contact Us 119
27.10 Disclaimer 119

Executive Summary

1.2 List of Figures
Figure 1: Healthcare Financing in Republic of Korea, 2007 24
Figure 2: Healthcare Expenditure in Republic of Korea, 2000 - 2006 25
Figure 3: Evaluation (Value Appraisal) Criteria for Medical Device Reimbursement in Republic of Korea, 2007 35
Figure 4: Medical Device Pricing System in Republic of Korea, 2007 36
Figure 5: In Vitro Diagnostics Cross Country Comparison (2000-2012) 38
Figure 6: In Vitro Diagnostics, Republic of Korea, Overall Revenues ($ mn), 2000-2012 39
Figure 7: In Vitro Diagnostics, Republic of Korea, Portfolio Analysis, 2000-2012 40
Figure 8: In Vitro Diagnostics, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 41
Figure 9: In Vitro Diagnostics, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 43
Figure 10: In Vitro Diagnostics, Republic of Korea Company Share (%), 2007 45
Figure 11: Blood Test Reagents, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007 46
Figure 12: Blood Test Reagents, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012 48
Figure 13: Haematology Test Reagents, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 50
Figure 14: Haematology Test Reagents, Republic of Korea, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 51
Figure 15: Hemostasis Test Reagents, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 52
Figure 16: Hemostasis Test Reagents, Republic of Korea, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 53
Figure 17: Blood Test Reagents, Republic of Korea, Company Share (%), 2007 55
Figure 18: Clinical Chemistry Test Reagents, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007 56
Figure 19: Clinical Chemistry Test Reagents, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012 57
Figure 20: Clinical Chemistry Test Reagents, Republic of Korea, Company Share (%), 2007 59
Figure 21: Genetic Test Reagents, Republic of Korea, Revenue ($ mn), Historic, 2000-2007 60
Figure 22: Genetic Test Reagents, Republic of Korea, Revenue ($ mn), Forecast, 2007-2012 61
Figure 23: Genetic Test Reagents, Republic of Korea, Company Share (%), 2007 63
Figure 24: Immunochemistry Test Reagents, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007 64
Figure 25: Immunochemistry Test Reagents, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012 66
Figure 26: Disease Specific Markers, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 68
Figure 27: Disease Specific Markers, Republic of Korea, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 69
Figure 28: Disease Specific Test Reagents, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 70
Figure 29: Disease Specific Test Reagents, Republic of Korea, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 71
Figure 30: Drug Related Testing Reagents, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 72
Figure 31: Drug Related Testing Reagents, Republic of Korea, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 73
Figure 32: Hormone Related Testing Reagents, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 74
Figure 33: Hormone Related Testing Reagents, Republic of Korea, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 75
Figure 34: Immunochemistry Test Reagents, Republic of Korea, Company Share (%), 2007 77
Figure 35: Infectious Immunology Test Reagents, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007 78
Figure 36: Infectious Immunology Test Reagents, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012 80
Figure 37: Virology, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 82
Figure 38: Virology, Republic of Korea, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 83
Figure 39: Infectious Immunology Test Reagents, Republic of Korea, Company Share (%), 2007 85
Figure 40: Instruments, Republic of Korea, Revenue ($ mn), Historic, 2000-2007 86
Figure 41: Instruments, Republic of Korea, Revenue ($ mn), Forecast, 2007-2012 87
Figure 42: Bacteriology Test Reagents, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 90
Figure 43: Bacteriology Test Reagents, Republic of Korea, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 91
Figure 44: Microbiology Test Reagents, Republic of Korea, Company Share (%), 2007 93
Figure 45: Self Testing, Republic of Korea, Revenue ($ mn), Historic, 2000-2007 94
Figure 46: Self Testing, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012 95
Figure 47: Self Testing, Republic of Korea, Company Share (%), 2007 97
Figure 48: F. Hoffmann-La Roche Ltd Value Chain Analysis 98
Figure 49: Abbott Laboratories Value Chain Analysis 101
Figure 50: Beckman Coulter, Inc. Value Chain Analysis 105
Figure 51: Becton, Dickinson and Company Value Chain Analysis 112
Figure 52: Global Markets Direct Methodology 118


Companies Mentioned F. Hoffmann-La Roche Ltd. Abbott Laboratories Beckman Coulter, Inc. Dade Behring Holdings, Inc. Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company Bioneer Corporation Biospace Co.,Ltd. Boditech Med Inc.


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/669754

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 16/02/2012 02:51:18
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Republic of Korea In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012
Web Address:
http://www.researchandmarkets.com/reports/669754
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €2,263.00
Electronic (PDF) - Site License €4,527.00
Electronic (PDF) - Enterprisewide €6,790.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 16/02/2012 02:51:18

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)